To Evaluate the Efficacy and Safety of SCT510 in the Treatment of Non-small Cell Lung Cancer

NCT03792074 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

560

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-squamous Cell Non-small Cell Lung Cancer

Interventions

DRUG: SCT510
DRUG: Bevacizumab
DRUG: Paclitaxel
DRUG: Carboplatin

Sponsor

Sinocelltech Ltd.